Join
Live feed
·
INSIDERFilingvia Quantisnow
Madrigal Pharmaceuticals Inc. logo

President and CEO Sibold William John sold $6,239,198 worth of shares (11,583 units at $538.65) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 197,746 units (SEC Form 4) (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
MDGL· Madrigal Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MDGL (Madrigal Pharmaceuticals Inc.) and more on Quantisnow.